Wall Street Desperately Seeks Details On Trump's Plan To Unclog Hormuz Chokepoint It's been wild ride in crude over the past few days with Brent crude futures were capped near $84 a barrel on Tuesday afternoon before sliding down to the $81 level late Wednesday afternoon, only to surge back up to $84 this morning... ...as shipping industry insiders and Wall Street analysts await exact details on the Trump administration's proposal to keep tankers transiting the Strait of Hormuz. The critical maritime chokepoint remains paralyzed, raising the risk of an energy shock in parts of the world that rely heavily on those flows, particularly in Asia. President Trump wrote in a Truth Social post that the U.S. will provide insurance for " ALL Maritime Trade " through the U.S. Development Finance Corporation (DFC) and will provide Navy escorts "if necessary." The shutdown is already hitting global energy flows: QatarEnergy Declares Force Majeure As One-Fifth Of Global LNG Supply Goes Dark Oil Spikes To Session High As Iraq Starts Shutting Output At Massive Oil Field Now comes the hard part, with the shipping industry and Wall Street analysts all asking the same question: how will every tanker transiting the Arabian Sea through the Gulf of Oman, into the Strait, and onward to the Persian Gulf be protected by U.S. or allied air or naval forces? "Nothing is sure and we need immediate clarity," said Khalid Hashim, managing director of Precious Shipping Pcl, a Thai firm that owns bulk carriers. Hashim said, "Lives are at risk, cargoes are at risk, ships are at risk. We need immediate cover that protects us from all this." While some shipowners say they're mulling over joining escorted convoys, many remain very cautious, noting that escorts do not eliminate the risk of the IRGC's asymmetric warfare, such as the use of drones. Analysts also question whether the Trump administration has done enough planning to make the proposal bulletproof in the near term. Overall, the market sees Tru...

格隆汇3月6日｜道琼斯指数向下跌破48000点，最新报47999.71点，日内下跌1.52%。标普500指数跌0.76%，纳指跌0.45%。纳斯达克中国金龙指数跌幅扩大，现跌2.0%，最新报6871.56点。

格隆汇3月6日｜美国商会表示，欧盟提议的《工业加速器法案》会造成不确定性和行政障碍，因此有抑制投资决策的风险。该组织首席执行官Malte Lohan表示：“《工业加速器法案》的部分内容有潜力吸引高质量投资、促进创新，并让欧洲继续走在脱碳的道路上。”“要想成功，欧盟必须避免过度和歧视性的要求，并保持单一市场对那些为欧洲繁荣和战略重点做出贡献的美国公司开放。”

Image source: The Motley Fool. Thursday, Mar. 5, 2026, at 8:30 a.m. ET Call participants Chief Executive Officer — Ofer Gonen Chief Financial Officer — Hani Luxenburg EVP, Strategy and Co-Development — Barry Wolfenson Takeaways Revenue -- $1.9 million in the quarter, down from $5.8 million, primarily due to a U.S. government shutdown delaying contract awards. -- $1.9 million in the quarter, down from $5.8 million, primarily due to a U.S. government shutdown delaying contract awards. Gross profit -- $300,000, with margin at 14.9%, compared to $900,000 or 15.5% in the prior period. -- $300,000, with margin at 14.9%, compared to $900,000 or 15.5% in the prior period. R&D expenses -- $4.5 million, up from $3.0 million, driven by Phase III investment in EscharEx. -- $4.5 million, up from $3.0 million, driven by Phase III investment in EscharEx. SG&A expenses -- $3.6 million, down from $4.0 million, mainly reflecting reduced marketing and share-based compensation. -- $3.6 million, down from $4.0 million, mainly reflecting reduced marketing and share-based compensation. Operating loss -- $7.8 million, compared to $6.1 million previously. -- $7.8 million, compared to $6.1 million previously. Net loss -- $7.2 million, or $0.56 per share, vs. $3.9 million, or $0.36 per share; increase tied to lower noncash financial income from warrant revaluation. -- $7.2 million, or $0.56 per share, vs. $3.9 million, or $0.36 per share; increase tied to lower noncash financial income from warrant revaluation. Adjusted EBITDA loss -- $6.5 million, compared to $4.9 million last year. -- $6.5 million, compared to $4.9 million last year. Full-year revenue -- $17.0 million versus $20.2 million; decline attributed to the U.S. government shutdown and lower sales to Vericel. -- $17.0 million versus $20.2 million; decline attributed to the U.S. government shutdown and lower sales to Vericel. Full-year gross margin -- 19.2%, improving from 13% due to a more favorable revenue mix. -- 19.2%, improving ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Archer Aviation secured 100% FAA acceptance of its Means of Compliance for its Midnight eVTOL aircraft, a key certification milestone for piloted passenger operations. The company began a restricted type certificate program with the UAE’s GCAA to support future commercial flights and vertiport development in Abu Dhabi. Archer is integrating NVIDIA’s IGX Thor platform for advanced autonomy and working with Starlink to add satellite based high speed connectivity to its aircraft. Archer Aviation (NYSE:ACHR) is trading at $6.76, with the stock showing a 138.0% return over 3 years and a 37.1% decline over 5 years. Over the past year, the share price is down 16.9%, and year to date performance is also a 16.9% decline. This gives recent news extra importance for investors tracking execution rather than short term moves. These certification advances, international programs and technology partnerships indicate that Archer is working to move its Midnight aircraft from concept toward commercial service in multiple regions. For investors watching NYSE:ACHR, the key questions now center on how quickly these regulatory and technology steps can translate into actual routes, paying passengers and scalable operations. Stay updated on the most important news stories for Archer Aviation by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Archer Aviation. NYSE:ACHR Earnings & Revenue Growth as at Mar 2026 We've flagged 3 risks for Archer Aviation. See which could impact your investment. Quick Assessment ✅ Price vs Analyst Target : At US$6.76, the price sits about 40% below the US$11.28 analyst target, which indicates a wide expectations gap. ✅ Simply Wall St Valuation : Simply Wall St estimates the shares are trading about 74.2% below fair value, highlight...

Oracle is fairly valued according to our Discounted Cash Flow (DCF) , but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act. On this basis, the DCF model estimates a fair value of US$160.28 per share, compared with the recent share price of US$152.37. That implies Oracle is trading at a 4.9% discount to this intrinsic value, which is a relatively small gap and suggests the market price is close to what this cash flow model implies. For Oracle, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections in $. The latest twelve month free cash flow is about $2.9b. Analysts provide explicit forecasts for the next few years, and Simply Wall St then extrapolates further out to build a ten year path, reaching a projected free cash flow of about $54.0b in 2035, with interim years that include both lower and higher figures. A DCF model takes estimates of a company’s future cash flows, discounts them back to today using a required return, and then sums them to arrive at an implied value per share. On Simply Wall St's valuation framework, Oracle currently scores 3 out of 6 . This suggests that some checks point to undervaluation while others do not. Next we will walk through the main valuation approaches before finishing with a more holistic way to think about what the stock could be worth. These mixed returns have kept Oracle on many investors' watchlists, as the stock price performance over different time frames can indicate shifting views on growth potential or risk. Recent coverage has focused on how Oracle fits into broader software and cloud discussions, which helps frame whether its current price feels justified or stretched. Oracle recently closed at US$152.37, with returns of 3.0% over the last 7 days, a 4.8% decline over 30 days, a 22.1% decline year to date, and a 4.7% decline over 1 year. The 3 year and 5 year returns sit at 78.5% and 126.2% respectively. If you are ...

Oracle is fairly valued according to our Discounted Cash Flow (DCF) , but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act. On this basis, the DCF model estimates a fair value of US$160.28 per share, compared with the recent share price of US$152.37. That implies Oracle is trading at a 4.9% discount to this intrinsic value, which is a relatively small gap and suggests the market price is close to what this cash flow model implies. For Oracle, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections in $. The latest twelve month free cash flow is about $2.9b. Analysts provide explicit forecasts for the next few years, and Simply Wall St then extrapolates further out to build a ten year path, reaching a projected free cash flow of about $54.0b in 2035, with interim years that include both lower and higher figures. A DCF model takes estimates of a company’s future cash flows, discounts them back to today using a required return, and then sums them to arrive at an implied value per share. On Simply Wall St's valuation framework, Oracle currently scores 3 out of 6 . This suggests that some checks point to undervaluation while others do not. Next we will walk through the main valuation approaches before finishing with a more holistic way to think about what the stock could be worth. These mixed returns have kept Oracle on many investors' watchlists, as the stock price performance over different time frames can indicate shifting views on growth potential or risk. Recent coverage has focused on how Oracle fits into broader software and cloud discussions, which helps frame whether its current price feels justified or stretched. Oracle recently closed at US$152.37, with returns of 3.0% over the last 7 days, a 4.8% decline over 30 days, a 22.1% decline year to date, and a 4.7% decline over 1 year. The 3 year and 5 year returns sit at 78.5% and 126.2% respectively. If you are ...

当地时间3月5日，以色列国防军宣布，以色列空军已对伊朗首都德黑兰的目标发动新一轮空袭。以军称，这是自本轮冲突开始以来对德黑兰发动的第13轮空袭，也是当天的第二轮空袭。 （央视新闻）

asiantiger247/iStock Editorial via Getty Images Summary I gave a hold rating to Keurig Dr Pepper ( KDP ) in July last year, as I was worried about the near-term operational uncertainty. Q4 has changed my view. The core US Refreshment Beverages is still executing well, Energy keeps adding another growth leg, and Coffee now looks more like a profit problem than a demand problem. That matters because I no longer need a full coffee recovery for the setup to improve. Earnings Results Update KDP Q4 showed another solid growth acceleration on a y/y basis. Net sales of ~$4.5 billion grew 10.5% y/y on a reported basis and 9.9% on a constant-currency basis [CCB]. Growth was driven by 6 points of net price realization and 3.9 points of volume/mix. GHOST added 3.6 points to volume/mix growth. US Refreshment Beverages contributed the most, with net sales up 11.5%, while US Coffee grew by 3.9%. But in terms of stand-alone growth, International was the fastest-growing segment. Net sales were up 21% to $604 million on a reported basis, or 16% CCB. Profits grew slower, though. Adj. EBIT only grew by 4.8% y/y as margin fell 120 bps to 26.5%. This was mostly due to US Coffee, which saw adj. EBIT is down 8.8% y/y. Elsewhere, US Refreshment Beverages adj. EBIT grew 8.7%, and International grew 20%. Consequently, adj. net income grew 2.3% to $813 million, and adj. diluted EPS was only up 1.7%. This is the Time to Be Bullish A quick recap on why I gave a hold rating: I believed the beverage side is good, but I didn’t want to take the risk on the coffee segment, margins, and tariffs dragging down the P&L. Fast forward to today, ~8 months later, I think the story has become much more bullish. Before I get to the bullish part, I acknowledge that Coffee is still weak. Profits were down, but don’t lose sight of the fact that the segment still grew 3.9% to $1.174 billion, with pricing strength (up 8 pts) offsetting negative volume/mix (down 4.1 pts). This shifts the narrative from being a “comp...

据美国《华盛顿邮报》5日报道，美国总统特朗普要求库尔德人协助美国在伊朗的行动，并表示将提供包括空中掩护在内的支持。报道援引多名知情人士的话说，特朗普本周与伊朗和伊拉克的库尔德领导人通话时表示，将提供“广泛的美国空中掩护”和其他支持，帮助“反政府的伊朗库尔德人占领伊朗西部部分地区”。报道说，伊拉克库尔德斯坦爱国联盟的一名高级官员表示，特朗普本月1日同该组织领导人通话时，要求伊拉克库尔德人为“在伊拉克的伊朗库尔德武装开放道路”。另据美国阿克西奥斯新闻网站报道，美国、以色列等官员透露，来自伊朗多个库尔德武装派别的武装人员正在为可能在伊朗西北部发动的地面进攻做准备。这些武装人员得到了以色列和美国情报机构的支持。报道说，特朗普1日与伊拉克库尔德自治区领导人巴尔扎尼和塔拉巴尼通电话，讨论冲突以及未来走向，但巴尔扎尼和塔拉巴尼都对“参与任何对伊朗的地面行动表示保留意见”。美国白宫新闻秘书莱维特4日证实特朗普已同库尔德领导人通电话，称讨论的内容“与我们在伊拉克北部的基地有关”，并否认有关特朗普同意武装库尔德人进攻伊朗计划的说法。（新华社）

gece33/iStock via Getty Images The conflict in the Middle East and its immediate—and most likely material—impact on fuel prices have acute ramifications on operating costs for the airline sector. Although U.S. carriers have a limited exposure to flights in the region, the detrimental impact on costs led Rothschild-Redburn to downgrade American Airlines to Neutral from Buy to reflect the carrier’s heightened sensitivity to fuel prices. Entering 2026, the outlook for the airline industry was generally favorable thanks to improving demand and “rational supply-side dynamics.” But with the Iran conflict added to the mix of increased domestic capacity, Rothschild-Redburn sees increased headwinds for the more vulnerable carriers. “Given the correlation between jet fuel prices and EBIT margins, as U.S. airlines do not hedge jet fuel, further increases to oil prices from these levels add substantial pressure to our forecasts,” Rothschild-Redburn analyst James Goodall writes in his note to clients. While fuel represents a relatively similar share of revenue and costs for each of the U.S. carriers, Goodall believes the diverging margin profiles mean there is a “substantial” difference in fuel as a percentage of EBIT. For example, in 2025, Goodall notes that fuel represented 1000% of Southwest’s ( LUV ) EBIT but just 170% for Delta ( DAL ). Using a model that assumes each $0.10 move in jet fuel per gallon results in a $0.30 to $0.40 impact to EPS, this makes American Airlines ( AAL ) the most sensitive to fuel prices and Delta ( DAL ) and United ( UAL ) less so. “Clearly, the airlines will react to the higher jet fuel prices by attempting to pass through the higher costs to consumers to mitigate the impact; as such, we have increased our pricing assumptions this year,” Goodall adds. As far as how the Iran conflict will impact operations, United has the greatest exposure to the Middle East, with the area representing 4% of scheduled international available seat miles (ASM) follo...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Coherent (NYSE:COHR) has entered a multiyear alliance with NVIDIA that includes a $2 billion investment into Coherent. NVIDIA has also agreed to multibillion dollar purchase commitments for Coherent’s advanced laser and optical networking products. The partnership focuses on accelerating next generation optics and expanding U.S. manufacturing capacity for AI data center infrastructure. For investors watching AI infrastructure, Coherent is moving into the spotlight. The stock trades at $274.86 and has logged a 41.4% return year to date and a 282.6% return over the past year. That move, combined with this new NVIDIA alliance, puts NYSE:COHR firmly on the radar of investors tracking picks and shovels for AI growth. The deal positions Coherent as a key supplier of optical and laser components that support large AI data centers. As the partnership unfolds, investors may focus on how quickly purchase commitments translate into capacity buildout, revenue concentration with NVIDIA, and any follow-on agreements with other large AI customers. Stay updated on the most important news stories for Coherent by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Coherent. NYSE:COHR Earnings & Revenue Growth as at Mar 2026 2 things going right for Coherent that this headline doesn't cover. This partnership ties Coherent much more tightly into the AI supply chain, with NVIDIA effectively becoming both a large customer and a new shareholder. The multibillion dollar purchase commitments and US$2b equity investment signal that Coherent’s optical and laser roadmap lines up with what high performance AI data centers need, particularly around high bandwidth, energy efficient interconnects. At the same time, this kind of anchor customer can concentrate revenue and raise execution pressure around yield, capacity ramp and delive...

关键要点 纽约州总检察长利蒂希娅·詹姆斯及其他州检察官提起诉讼，要求阻止特朗普的新关税，并在最高法院否决其此前依据《国际紧急经济权力法》实施的关税后，要求退还已缴税款。 诉讼称，特朗普滥用了《1974年贸易法》第122条，违反了宪法及要求关税统一适用的法定规则。 此举紧随最高法院否决特朗普原有关税之后，且特朗普与詹姆斯此前已有法律冲突，后者曾遭联邦起诉但已被驳回且未重启。 纽约州总检察长利蒂希娅·詹姆斯及其他23个州的总检察长再次提起诉讼，试图阻止总统唐纳德·特朗普的全球关税制度，而就在几天前，最高法院刚刚作出了一项具有里程碑意义的裁决，否决了他此前的关税努力。 他们于周四向国际贸易法院提起的诉讼，旨在宣布特朗普的最新关税为非法，并命令向各州退还税款。 上个月，最高法院否决了特朗普去年实施的、涵盖范围广泛的“解放日”关税中的大部分，称其利用《国际紧急经济权力法》征收关税的做法不当。 但总统试图通过立即宣布新一轮关税来维持其标志性政策，此次依据的是另一项法律——《1974年贸易法》第122条。目前的全球关税税率定为10%，但特朗普政府表示计划将其提高到15%。 “在最高法院驳回了他首次征收全面关税的尝试后，总统正在制造更多的经济混乱，并指望美国人为此买单，”詹姆斯在提供给CNBC的一份声明中表示。 “特朗普总统无视法律和宪法，实际上是在对消费者和小企业增税，”她说。 这个由多州总检察长组成的联盟（其中大多数曾成功参与阻止特朗普原有关税的行动）的举措，加剧了总统关税政策造成的持续国际不确定性。周三，一家联邦法院裁定，那些为上个月被最高法院否决的关税支付了税款的公司，有权获得数十亿美元的退款。 滥用法律 在诉讼中，詹姆斯及其联盟认为，特朗普滥用了《1974年贸易法》第122条。他们称，该条款旨在应对美国实行金本位制时可能出现的特定货币失衡问题，而非用于解决贸易失衡问题。 这些总检察长还辩称，这些关税违反了宪法赋予国会征税权的三权分立原则，并且特朗普的征税违反了《1974年贸易法》关于关税应在各国间统一适用的要求。 根据詹姆斯的说法，此举是“试图逃避最高法院在针对依据《国际紧急经济权力法》实施的关税案中裁决的明显尝试”。 去年，詹姆斯与其他11个州起诉特朗普政府，要求停止其第一轮关税。这一行动最终与受关税影响的小企业提起的诉讼合并，并在最高法院案件中导致特朗普在其第二任期内...

Women’s History Month is upon us in the US (and soon we’ll be celebrating International Women’s Day in many parts of the world). Even as headlines reflect global turmoil, it’s a moment to honor some of the great women in finance of the past — an enlightened group that unsurprisingly hit obstacles at every turn and still pressed ahead. Ever heard of Victoria Woodhull ? She was the first woman to run for US president! That was in 1872. Two years earlier, she opened the first female-owned brokerage in New York with her sister, holding the opinion that earning money was better protection against the “tyranny” of men than the right to vote. Advice that never gets old. More enlightenment from the past later. Let’s turn to the present. As ever, there’s so much news we’ve been busy with, from a spreading war across the Middle East to the drip drip of revelations from the Epstein files. In the background, there’s a potentially critical shift underway at the European Central Bank. So let’s talk about one of the most influential women of our generation — Christine Lagarde . Will she, won’t she? That’s suddenly the biggest guessing game in European monetary policy. In mid‑February, the Financial Times reported that Lagarde is preparing to leave the ECB before her eight‑year term ends in October 2027, with an eye to stepping down ahead of next year’s French presidential election. The idea, according to people familiar with the discussions, is to give Emmanuel Macron a chance to help select a successor while he’s still in office. Officially, Lagarde is being deliberately vague. Asked whether she’ll serve her full term, she repeated that her “baseline” is to stay until October 2027 , while the ECB insists that no decision has been taken and that she remains “totally focused” on her mandate. The politics around the timing are as interesting as the economics. An early exit would let a lame‑duck Macron and German Chancellor Friedrich Merz lock in an ECB president able to resist press...

阿联酋告知迪拜居民，因导弹威胁，请寻找避难场所。

Source: Bloomberg, 3:14

Investing.com -- Astera Labs has received a bullish rating from Loop Capital in a note on Thursday, with the firm assigning the stock a Buy rating and a $250 price target, citing the company’s positioning at the centre of what it calls an artificial intelligence “super-cycle.” Loop Capital analyst Ananda Baruah states that the semiconductor firm represents one of the clearest ways for investors to gain exposure to AI infrastructure beyond dominant chipmakers. “We’re initiating with a Buy and a $250 PT as we see ALAB as the company most representing a diversified AI silicon ‘pure play’ (outside of NVDA),” Baruah wrote in a research note. The analyst said Astera Labs is well-positioned across the rapidly expanding ecosystem of AI processors, including GPUs and alternative accelerators. According to Loop Capital, the company “has opportunity across essentially all Gen AI silicon flavors (GPU, Tranium, TPU and the other XPUs)” through solutions designed to address key challenges in AI server and cluster performance. Loop Capital argues that the increasing scale and complexity of AI infrastructure will make Astera Labs’ technology increasingly essential. “As servers and clusters become larger and more sophisticated (i.e. increasingly complex), ALAB becomes more both critical and valuable,” the note said. The firm also highlighted the growing diversity of AI accelerators beyond those produced by NVIDIA, saying this shift could significantly expand Astera Labs’ revenue opportunity. Over time, Loop Capital believes the company could build durable competitive advantages. Baruah believes Astera Labs’ predictive software and management platform, COSMOS, “could become industry standard and a real performance amplifier,” potentially creating “moat-like stickiness” with customers as AI infrastructure scales. Related articles Astera Labs gets new buy rating amid AI supercyle Goldman expects lower but still attractive stock market returns in 2026 As Claude disrupts stock market, An...

Mixed options sentiment in Oracle (ORCL), with shares up $3.09, or 2.07%, near $152.10. Options volume relatively light with 74k contracts traded and calls leading puts for a put/call ratio of 0.45, compared to a typical level near 1.27. Implied volatility (IV30) dropped 1.45 near 71.13, in the highest 10% of observations over the past year, suggesting an expected daily move of $6.82. Put-call skew steepened, indicating increased demand for downside protection.Looking ahead: Oracle (ORCL) will report earnings after the close on 2026-03-10.Option markets are pricing in a 50% probability of a move greater than 10.71% or $16.30. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ORCL: Disclaimer & DisclosureReport an Issue

Investing.com -- Astera Labs has received a bullish rating from Loop Capital in a note on Thursday, with the firm assigning the stock a Buy rating and a $250 price target, citing the company’s positioning at the centre of what it calls an artificial intelligence “super-cycle.” Loop Capital analyst Ananda Baruah states that the semiconductor firm represents one of the clearest ways for investors to gain exposure to AI infrastructure beyond dominant chipmakers. “We’re initiating with a Buy and a $250 PT as we see ALAB as the company most representing a diversified AI silicon ‘pure play’ (outside of NVDA),” Baruah wrote in a research note. The analyst said Astera Labs is well-positioned across the rapidly expanding ecosystem of AI processors, including GPUs and alternative accelerators. According to Loop Capital, the company “has opportunity across essentially all Gen AI silicon flavors (GPU, Tranium, TPU and the other XPUs)” through solutions designed to address key challenges in AI server and cluster performance. Loop Capital argues that the increasing scale and complexity of AI infrastructure will make Astera Labs’ technology increasingly essential. “As servers and clusters become larger and more sophisticated (i.e. increasingly complex), ALAB becomes more both critical and valuable,” the note said. The firm also highlighted the growing diversity of AI accelerators beyond those produced by NVIDIA, saying this shift could significantly expand Astera Labs’ revenue opportunity. Over time, Loop Capital believes the company could build durable competitive advantages. Baruah believes Astera Labs’ predictive software and management platform, COSMOS, “could become industry standard and a real performance amplifier,” potentially creating “moat-like stickiness” with customers as AI infrastructure scales. Related articles Astera Labs gets new buy rating amid AI supercyle As Claude disrupts stock market, Anthropic researcher warns ’world is in peril’ Wolfe Research outlines eig...

Astera Labs Gets a Buy Rating. How the AI Semi Stock Could More Than Double. Barron's

Astera Labs has slumped nearly 30% so far into 2026 but this formerly red-hot semiconductor stock is worth a second look. Shares pulled back as recently as February after Astera announced the hiring of a new chief financial officer.

Astera Labs Stock Initiated at Buy. Why It Can Still Be an AI Winner. Barron's

Iskandar Zulkarnaen/iStock via Getty Images Thesis Summary While everyone is looking at Iran, the KOSPI ( KOSPI ) has crashed 20% in the last two days. That’s the index tracking the South Korean markets, and it has big repercussions for U.S. investors. South Korea sits at the heart of the AI hardware ecosystem, and as this trade unwinds, the repercussions could quickly spread to the West too. So, should investors be worried, or is it perhaps time to buy the dip in South Korean stocks? What Actually Happened The sell-off began when the KOSPI dropped more than 12% in a single session, followed by another brutal decline the next day. Trading was halted multiple times as this sudden surge in volatility triggered circuit breakers. To put this into perspective, South Korean stocks ( EWY ) have more than doubled in the last year. This is because a large part of the index is made up of AI hardware stocks like Samsung Electronics and SK hynix. And these stocks have also led the decline. But what triggered this sell-off? I can think of two key catalysts. Energy exposure Leverage Let’s break this down below. The Energy Shock South Korea is, with good reason, regarded as one of the most technologically advanced countries in the world. And yet, technology isn't everything, and South Korea produces almost none of its own energy. The country is, in fact, one of the largest importers of oil and LNG in the world. This is undeniably a point of weakness. South Korea’s industry is highly sensitive to changes in the oil and energy market, and there’s not much it can do about it. As the conflict in the Middle East escalated, Asian LNG prices surged to $25.40 per million BTU, doubling in just a week. Meanwhile, Qatar, one of Korea’s key suppliers, suspended some output, tightening supply even further. That’s a major problem for a country whose entire economic model is built on exporting manufactured goods. Higher energy prices would eventually lead to tighter margins and potentially even ...

Image source: The Motley Fool. March 5, 2026, 8:30 a.m. ET Call participants Chairman of the Board — Marc Elia Chief Commercial Officer — Timothy Lee Chief Financial Officer — William Duke Chief Scientific Officer — Dr. Robert Allen Senior Vice President of Finance — Katie Falzone Need a quote from a Motley Fool analyst? Email [email protected] Takeaways PEMGARDA net revenue growth -- Net revenues increased 31% over the third quarter of 2025 and 25% compared to the fourth quarter of 2024, demonstrating continued product uptake. -- Net revenues increased 31% over the third quarter of 2025 and 25% compared to the fourth quarter of 2024, demonstrating continued product uptake. Full year 2025 net revenues -- Totaled $53.4 million, reflecting ongoing market awareness efforts. -- Totaled $53.4 million, reflecting ongoing market awareness efforts. Cash and cash equivalents -- Year-end balance reached $226.7 million, following over $200 million in capital raised during 2025. -- Year-end balance reached $226.7 million, following over $200 million in capital raised during 2025. PEMGARDA account reordering rate -- 77% of accounts reordered, indicating solid repeat adoption. -- 77% of accounts reordered, indicating solid repeat adoption. Contracted GPO sites -- Over 15,000 sites secured nationally, expanding the commercial footprint across specialties. -- Over 15,000 sites secured nationally, expanding the commercial footprint across specialties. VYD2311 clinical program progress -- Declaration study achieved target enrollment of approximately 1,770 subjects, with modest over-enrollment possible. -- Declaration study achieved target enrollment of approximately 1,770 subjects, with modest over-enrollment possible. Declaration study IDMC safety review -- The committee recommended allowing enrollment of pregnant and breastfeeding women, removal of required contraception for women of childbearing age, and elimination of prespecified safety visits at days 8, 38, and 68 post dosing. ...

In this article AVGO Follow your favorite stocks CREATE FREE ACCOUNT watch now VIDEO 2:43 02:43 Broadcom CEO: AI revenue from chips could exceed $100 billion in 2027 Fast Money Broadcom 's stock surged about 5% on Thursday as CEO Hock Tan touted strong demand for the company's chips amid the artificial intelligence boom. He told analysts on Wednesday that he anticipates AI chip revenue in 2027 that's "significantly in excess of $100 billion" as demand mounts for designing custom silicon. That far surpassed many bullish estimates from Wall Street analysts, who now anticipate more potential upside after Tan said the company is nearing 10 gigawatts of capacity between six customers. Analysts at JPMorgan estimate that the company can reach between $12 billion and $15 billion in revenue per gigawatt by 2027 and lifted the firm's AI revenue estimates "conservatively" to $120 billion or more. The company's "leadership in AI networking and custom silicon enables the lowest inference cost for its hyperscaler customers, and we see it delivering ongoing cost reductions on pace with market leader Nvidia," wrote analysts at Goldman Sachs. The comments came alongside Broadcom's better-than-expected quarterly results , in which AI revenue more than doubled due to AI accelerator and networking demand. Read more CNBC tech news 5 unresolved questions hanging over the Anthropic–Pentagon fracas: 'It's all very puzzling' Amazon's Bahrain data center targeted by Iran for support of U.S. military, state media says Broadcom CEO Hock Tan sees AI chip revenue 'significantly' above $100 billion next year Defense tech companies are dropping Claude after Pentagon's Anthropic blacklist Nvidia CEO Huang says $30 billion OpenAI investment 'might be the last' Over the last few months, chipmakers have grappled with a shortage in high-bandwidth memory as AI demand snaps up supply. But Tan told analysts that the company has secured memory and leading-edge wafer supply through 2028. Tan managed to conv...

Stocks with rising relative strength: Palantir Technologies MSN

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.

Image source: The Motley Fool. Thursday, March 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Dr. Yoav Zeif Chief Financial Officer — Eitan Zamir Vice President of Investor Relations — Yonah Lloyd TAKEAWAYS Consolidated Revenue -- $140 million for the quarter, down 6.9% year over year; $551.1 million for the year, down from $572.5 million. -- $140 million for the quarter, down 6.9% year over year; $551.1 million for the year, down from $572.5 million. Product Revenue -- $97.6 million in the quarter (vs. $105.1 million prior year); $380.3 million for the year (vs. $392 million). -- $97.6 million in the quarter (vs. $105.1 million prior year); $380.3 million for the year (vs. $392 million). System Revenue -- $37.8 million for the quarter, up 18% sequentially from Q3, but down from $46.7 million year over year. -- $37.8 million for the quarter, up 18% sequentially from Q3, but down from $46.7 million year over year. Consumables Revenue -- $59.8 million in the quarter, up 2.4% year over year; $248.7 million for the year (vs. $261.7 million). -- $59.8 million in the quarter, up 2.4% year over year; $248.7 million for the year (vs. $261.7 million). Service Revenue -- $42.4 million in the quarter (vs. $45.3 million); $170.8 million for the year (vs. $180.5 million). -- $42.4 million in the quarter (vs. $45.3 million); $170.8 million for the year (vs. $180.5 million). GAAP Gross Margin -- 36.8% for the quarter (vs. 46.3%); 41.2% for the year (vs. 44.9%). -- 36.8% for the quarter (vs. 46.3%); 41.2% for the year (vs. 44.9%). Non-GAAP Gross Margin -- 46.3% for the quarter (vs. 49.6%); 46.9% for the year (vs. 49.2%). -- 46.3% for the quarter (vs. 49.6%); 46.9% for the year (vs. 49.2%). GAAP Operating Loss -- $20.8 million for the quarter (vs. $9.7 million); $72.5 million for the year (vs. $85.7 million). -- $20.8 million for the quarter (vs. $9.7 million); $72.5 million for the year (vs. $85.7 million). Non-GAAP Operating Income -- $4.1 million for the quar...

Image source: The Motley Fool. Thursday, March 5, 2026 at 8 a.m. ET REGENXBIO (NASDAQ:RGNX) provided operational updates highlighting late-stage clinical, regulatory, and financial developments that may influence investor sentiment and near-term strategy. The RGX-202 Duchenne pivotal trial reached full enrollment, with management emphasizing data indicating both functional and biomarker improvements, and advanced FDA interactions ahead of an anticipated accelerated approval pathway. Company leadership outlined Cirovec’s topline data readout schedules, a potential $100 million milestone upon first dosing in diabetic retinopathy, and noted durable efficacy and significant anti-VEGF injection reduction in prior dose cohorts. Management acknowledged ongoing regulatory challenges in the MPS franchise, reporting active engagement with the FDA following a clinical hold and a single observed AAV integration event temporally associated with tumor formation. Financially, the company cited partnership-based revenues, committed R&D investments, and a multi-year cash runway, noting further extension potential with upcoming milestones. Continue reading